Arcus Biosciences Inc
NYSE:RCUS
Cash Flow Statement
Cash Flow Statement
Arcus Biosciences Inc
Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | |||||||||||||||||||||||||||
Net Income |
(53)
|
(59)
|
(63)
|
(51)
|
(50)
|
(54)
|
(69)
|
(80)
|
(85)
|
(95)
|
(112)
|
(88)
|
(123)
|
(168)
|
(199)
|
(278)
|
53
|
57
|
67
|
80
|
(267)
|
(279)
|
(287)
|
(294)
|
(307)
|
(231)
|
|
Depreciation & Amortization |
3
|
3
|
3
|
4
|
4
|
4
|
4
|
4
|
4
|
3
|
3
|
3
|
3
|
3
|
3
|
3
|
4
|
5
|
5
|
6
|
6
|
7
|
7
|
7
|
8
|
9
|
|
Stock-Based Compensation |
0
|
1
|
2
|
3
|
4
|
5
|
6
|
8
|
9
|
11
|
13
|
16
|
22
|
31
|
40
|
49
|
55
|
59
|
61
|
62
|
65
|
67
|
70
|
72
|
73
|
0
|
|
Other Non-Cash Items |
1
|
2
|
1
|
1
|
2
|
2
|
4
|
6
|
8
|
9
|
12
|
16
|
23
|
33
|
44
|
54
|
63
|
72
|
76
|
77
|
76
|
70
|
67
|
65
|
64
|
83
|
|
Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
(3)
|
0
|
0
|
0
|
5
|
0
|
|
Change in Working Capital |
25
|
26
|
26
|
26
|
1
|
2
|
6
|
(1)
|
0
|
(6)
|
4
|
220
|
208
|
207
|
178
|
(23)
|
(376)
|
330
|
325
|
283
|
623
|
(112)
|
(92)
|
(66)
|
(71)
|
(71)
|
|
Cash from Operating Activities |
(25)
N/A
|
(29)
-14%
|
(33)
-14%
|
(20)
+38%
|
(43)
-111%
|
(47)
-8%
|
(56)
-19%
|
(71)
-28%
|
(74)
-3%
|
(88)
-20%
|
(92)
-5%
|
152
N/A
|
111
-27%
|
76
-31%
|
26
-66%
|
(244)
N/A
|
(256)
-5%
|
464
N/A
|
473
+2%
|
446
-6%
|
438
-2%
|
(314)
N/A
|
(306)
+3%
|
(288)
+6%
|
(306)
-6%
|
(210)
+31%
|
|
Investing Cash Flow | |||||||||||||||||||||||||||
Capital Expenditures |
(6)
|
(5)
|
(4)
|
(4)
|
(4)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(1)
|
(2)
|
(3)
|
(7)
|
(12)
|
(19)
|
(26)
|
(25)
|
(21)
|
(14)
|
(6)
|
(6)
|
(10)
|
(18)
|
(24)
|
(25)
|
|
Other Items |
(44)
|
(45)
|
(59)
|
(154)
|
(110)
|
(79)
|
(37)
|
76
|
61
|
87
|
(28)
|
(445)
|
(431)
|
(405)
|
(309)
|
(4)
|
22
|
(310)
|
(532)
|
(427)
|
(407)
|
(10)
|
235
|
231
|
218
|
(79)
|
|
Cash from Investing Activities |
(49)
N/A
|
(49)
N/A
|
(62)
-26%
|
(158)
-155%
|
(113)
+28%
|
(83)
+27%
|
(40)
+52%
|
74
N/A
|
59
-20%
|
85
+44%
|
(29)
N/A
|
(446)
-1 449%
|
(434)
+3%
|
(412)
+5%
|
(322)
+22%
|
(23)
+93%
|
(4)
+83%
|
(335)
-8 485%
|
(553)
-65%
|
(441)
+20%
|
(413)
+6%
|
(16)
+96%
|
225
N/A
|
213
-6%
|
194
-9%
|
(104)
N/A
|
|
Financing Cash Flow | |||||||||||||||||||||||||||
Net Issuance of Common Stock |
108
|
237
|
236
|
235
|
129
|
(0)
|
1
|
1
|
1
|
2
|
330
|
438
|
439
|
660
|
334
|
227
|
232
|
20
|
22
|
23
|
23
|
14
|
33
|
36
|
33
|
261
|
|
Other |
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
10
|
10
|
10
|
10
|
5
|
5
|
5
|
0
|
0
|
|
Cash from Financing Activities |
107
N/A
|
237
+120%
|
235
-1%
|
235
0%
|
129
-45%
|
(0)
N/A
|
1
N/A
|
1
N/A
|
1
-21%
|
2
+55%
|
330
+19 312%
|
438
+33%
|
439
+0%
|
660
+50%
|
334
-49%
|
227
-32%
|
237
+4%
|
30
-87%
|
32
+7%
|
33
+4%
|
33
-1%
|
19
-42%
|
38
+97%
|
41
+9%
|
33
-20%
|
261
+691%
|
|
Change in Cash | |||||||||||||||||||||||||||
Net Change in Cash |
33
N/A
|
159
+379%
|
140
-12%
|
56
-60%
|
(27)
N/A
|
(130)
-374%
|
(94)
+27%
|
4
N/A
|
(13)
N/A
|
(1)
+90%
|
209
N/A
|
143
-32%
|
116
-19%
|
325
+181%
|
38
-88%
|
(40)
N/A
|
(23)
+43%
|
159
N/A
|
(48)
N/A
|
38
N/A
|
58
+52%
|
(311)
N/A
|
(43)
+86%
|
(34)
+21%
|
(79)
-134%
|
(53)
+33%
|
|
Free Cash Flow | |||||||||||||||||||||||||||
Free Cash Flow |
(31)
N/A
|
(33)
-8%
|
(36)
-9%
|
(24)
+33%
|
(47)
-93%
|
(50)
-7%
|
(58)
-16%
|
(73)
-26%
|
(75)
-3%
|
(90)
-19%
|
(93)
-4%
|
150
N/A
|
108
-28%
|
70
-36%
|
14
-80%
|
(263)
N/A
|
(282)
-7%
|
439
N/A
|
452
+3%
|
432
-5%
|
432
+0%
|
(320)
N/A
|
(315)
+1%
|
(306)
+3%
|
(330)
-8%
|
(235)
+29%
|